These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 6399981
1. CEA and ABO(H) in upper urinary tract transitional tumors. Dalla Palma P, Parenti A, Poletti A. Appl Pathol; 1984; 2(3):146-52. PubMed ID: 6399981 [Abstract] [Full Text] [Related]
2. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors]. Fujioka T, Tanji S, Koike H, Kubo T, Ohhori T. Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765 [Abstract] [Full Text] [Related]
6. [CEA and ABO antigens as early signs of malignancy in urotheliomas of the upper urinary tract]. Cisternino A, Argona F, Garbeglio A, Ranieri A, Bassi P, Pergoraro V. Arch Esp Urol; 1986 Oct; 39(8):529-33. PubMed ID: 3827317 [No Abstract] [Full Text] [Related]
11. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study]. Lanzafame S, Puzzo L, Di Naso C, Di Marco G, Ranno S, Minardi G. Pathologica; 1986 Sep; 78(1056):451-8. PubMed ID: 3302887 [No Abstract] [Full Text] [Related]
12. The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinary tract: a report of 102 new cases. Fujikawa K, Matsui Y, Oka H, Fukuzawa S, Sasaki M, Takeuchi H. J Urol; 2000 Aug; 164(2):352-5. PubMed ID: 10893583 [Abstract] [Full Text] [Related]
14. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662 [Abstract] [Full Text] [Related]
17. [Prognostic criteria in patients with renal pelvic and ureteral cancers--clinical value of volume weighted mean nuclear volume]. Aoyama T, Fujikawa K, Sasaki M. Hinyokika Kiyo; 1996 Nov; 42(11):841-5. PubMed ID: 8973933 [Abstract] [Full Text] [Related]
18. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. Criteria for the loss of BGA based on the staining pattern by the PAP method and its correlation with CEA and fibronectin]. Nasu Y. Nihon Hinyokika Gakkai Zasshi; 1986 Jun; 77(6):977-87. PubMed ID: 3534405 [No Abstract] [Full Text] [Related]
19. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival. Miyata Y, Kanda S, Nomata K, Hayashida Y, Kanetake H. Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476 [Abstract] [Full Text] [Related]
20. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system. Holmäng S, Johansson SL. Urology; 2005 Aug; 66(2):274-8. PubMed ID: 16098355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]